Stability-indicating HPLC method for posaconazole bulk assay

Scientia Pharmaceutica

Volumn 80, Issue 2, 2012, Pages 317-327

  Garcia, Cássia V ^a   Costa, Gislaine R ^b   Mendez, Andreas S L ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

Bulk; HPLC; Posaconazole; Stability indicating assay; Stress conditions; Triazoles

Indexed keywords

METHANOL; POSACONAZOLE; WATER;

ACCURACY; ARTICLE; BIOASSAY; DRUG ANALYSIS; DRUG RETENTION; DRUG STABILITY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; OXIDATION; QUANTITATIVE ANALYSIS;

EID: 84865112094     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1111-11     Document Type: Article

References (15)

1. Keating GM. Posaconazole. Drugs. 2005; 65: 1553-1567. doi:10.2165/00003495-200565110-00007
2. Kauffman CA, Malani A, Easley C, Kirkpatrick P. Posaconazole. Nat Rev Drug Discovery 2007; 6: 183-184. doi:10.1038/nrd2270
3. Thompson GR, Cadena J, Patterson TF. Overview of antifungal agents. Clin Chest Med. 2009; 30: 203-215. doi:10.1016/j.ccm.2009.02.001
4. Frampton JE, Scott L. Posaconazole. A review of its use in the prophylaxis of invasive fungal infections. Drugs. 2008; 68: 993-1016. doi:10.2165/00003495-200868070-00008
5. Kim H, Likhari P, Lin C, Nomeir A. High-performance liquid chromatographic analysis of the anti-fungal agent SCH56592 in dog serum. J Chromatogr B. 2000; 738: 93-98. doi:10.1016/S0378-4347(99)00489-2
6. Kim H, Kumari P, Laughlin M, Hilbert M, Indelicato S, Lim J, Lin C, Nomeir A. Use of high-performance liquid chromatographic and microbiological analysis for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma. J Chromatogr A. 2003; 987: 243-248. doi:10.1016/S0021-9673(02)01599-6
7. Shen J, Krishna G, Hayes R. A sensitive liquid chromatography and mass spectrometry method for the determination of posaconazole in human plasma. J Pharm Biomed Anal. 2007; 43: 228-236. doi:10.1016/j.jpba.2006.06.011
8. Chhun S, Rey E, Tran A, Lortholary O, Pons G, Jullien V. Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection. J Chromatogr B. 2007; 852: 223-228. doi:10.1016/j.jchromb.2007.01.021
9. Cunliffe J, Noren C, Hayes R, Clement R, Shen J. A high-throughput LC-MS/MS method for the quantification of posaconazole in human plasma: implementing fused core silica liquid chromatography. J Pharm Biomed Anal. 2009; 50: 46-52. doi:10.1016/j.jpba.2009.03.034
10. Alffenaar JWC, Wessels AMA, van Hateren K, Greijdanus B, Kosterink JG, Uges DRA. Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS. J Chromatogr B. 2010; 878: 39-44. doi: 10.1016/j.jchromb.2009.11.017
11. Ekiert RJ, Krzec J, Talik P. Chromatographic and electrophoretic techniques used in the analysis of triazole antifungal agents - a review. Talanta. 2010; 82: 1090-1100. doi:10.1016/j.talanta.2010.06.056
12. ICH Q2 (R1), International Conference on Harmonization. Validation of Analytical Procedure: Text and Methodology, 2005.
13. BRASIL. Agência Nacional de Vigilância Sanitária. RE 899 - Validação de Métodos Analíticos e Bioanalíticos, 2003.
14. US Pharmacopoeia XXXI. US Pharmacopeial Convention, Rockville, MD, 2008.
15. ICH Q1A (R2), International Conference on Harmonization. Stability Testing of New Drug Substance and Products: Text and Methodology, 2003.